Unknown

Dataset Information

Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.


ABSTRACT: Natural killer (NK) cells have gained attention as a promising adoptive cell therapy platform for their potential to improve cancer treatments. NK cells offer distinct advantages over T-cells, including major histocompatibility complex class I (MHC-I)-independent tumor recognition and low risk of toxicity, even in an allogeneic setting. Despite this tremendous potential, challenges persist, such as limited in vivo persistence, reduced tumor infiltration, and low absolute NK cell numbers. This review outlines several strategies aiming to overcome these challenges. The developed strategies include optimizing NK cell expansion methods and improving NK cell antitumor responses by cytokine stimulation and genetic manipulations. Using K562 cells expressing membrane IL-15 or IL-21 with or

SUBMITTER: Maia A 

PROVIDER: S-EPMC10930942 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature